ED
DISCK

Exane Derivatives’s Discovery, Inc. Series C Common Stock DISCK Stock Holding History

Exane Derivatives’s Portfolio DISCK Stock Details DISCK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-34,807
Closed -$797K – 1099
2021
Q4 		$797K Buy
34,807
+1,998
+6% +$48.1K 0.19% 113
2021
Q3 		$796K Buy
+32,809
New +$877K 0.19% 113

Other funds holding DISCK

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SAM
Southeastern Asset Management Memphis, Tennessee $2.03B AUM 7.06% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SCM
Smead Capital Management Phoenix, Arizona $4.6B AUM 27.56% 1-Year Est. Return

Exane Derivatives's DISCK Position: Q1 2022 in Review

Exane Derivatives sold out of Discovery, Inc. Series C Common Stock (DISCK) in Q1 2022, closing a stake of 34,807 shares — an estimated $797K sold.

Exane Derivatives first reported a position in DISCK in Q3 2021 and held it in 2 quarters. The position peaked at $797K in Q4 2021. 505 funds tracked by Wall St. Rank hold DISCK as of Q1 2022.

  • Exane Derivatives reported no remaining Discovery, Inc. Series C Common Stock position as of Q1 2022 after selling out during the quarter.
  • Exane Derivatives sold 34,807 Discovery, Inc. Series C Common Stock shares in Q1 2022, an estimated $797K.
  • Exane Derivatives first reported a position in Discovery, Inc. Series C Common Stock in Q3 2021 and held it in 2 quarters.
  • Exane Derivatives's Discovery, Inc. Series C Common Stock position peaked at $797K in Q4 2021.
  • 505 funds tracked by Wall St. Rank held Discovery, Inc. Series C Common Stock as of Q1 2022.

Based on Exane Derivatives's 13F filing for Q1 2022, filed 22 Apr 2022.